GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
F

Forza Innovations FORZ · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2024

Revenue

$114,596

FY2016FY2024

Net income

−$4.8m

FY2016FY2024

Free cash flow

−$845,844

FY2016FY2024

Shareholders' equity

−$4.6m

FY2016FY2024

Income statement

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$114,596$114,596$25,871$605,433$605,433$768,787$236,858$1,357—
Operating income−$926,658−$926,658−$1.9m−$60,165−$24,670$162,413−$68,395−$47,414−$8,516
Net income−$4.8m−$4.8m−$2.7m−$3.2m−$321,008$102,743−$76,292−$47,414−$8,516
Diluted earnings per share-0.01-0.00-0.01-0.01-0.000.00-0.00-0.00-0.00

Balance sheet

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$91,404$91,404$462,556$137,881$848,238$625,421$525,545$21,358$1,231
Cash and short-term investments——$295,914$13,677—$170,205$17,866$20,844$100
Total liabilities$4.7m$4.7m$1.8m$420,611$787,828$527,003$529,870$6,891$10,750
Debt$1.8m—$927,840$272,729$360,980$352,148$402,034——
Shareholders' equity−$4.6m−$4.6m−$1.3m−$282,730$60,410$98,418−$4,325$14,467−$9,519
Shares outstanding771m1,457m534m289m181m180m179m176m175m

Cash flow

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−$763,535−$763,535−$712,145$66,297−$153,266$225,157−$101,314−$53,346−$650
Capital spending−$82,309−$82,309−$75,612−$40,000−$40,000−$57,763−$397,306−$197,306—
Free cash flow−$845,844−$845,844−$787,757$26,297−$193,266$167,394−$498,620−$250,652−$650

Latest quarters

By quarter end

Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022
Revenue$7,756$32,232$32,233$14,044$39,954$31,615$28,983$25,871
Operating income−$17,335−$1,520−$1,524$316,605−$297,972−$431,989−$513,302−$361,701
Net income$878,756−$648,101−$648,101−$2.0m−$1.1m−$1.3m−$1.2m−$352,795
Diluted earnings per share0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00
Capital spending—−$82.0m——————
Total assets$73,400$88,391$88,391$91,404$252,148$281,767$504,271$462,556
Cash and short-term investments$1,214———$12,638$51,517$274,478—
Debt$2.1m$2.0m——$1.5m$1.3m$1.3m—
Shareholders' equity−$4.3m−$5.2m−$5.2m−$4.6m−$2.7m−$1.9m−$1.6m−$1.3m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-42.6%-31.7%—
Operating income148.8%——
Net income14.3%——

Valuation history

At each fiscal year end

FY2024FY2023FY2022FY2021
Price to earnings-0.0-0.0—-0.0
Price to sales0.70.90.00.0

Share price return

Finished calendar years

2025202420232022202120202019
Return-0%100%3900%-99%1288%99321%219%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 10-for-1 split · 17 Jun 2021

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.